Stockhead TV
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on LTR Pharma.
RELATED STOCKHEAD STORIES
News
Closing Bell: Aussie shares slip on commodities dip; but Goldies soar on rates hopes
Health & Biotech
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year
Health & Biotech
Check Up: Alzheimer’s is ‘preventable’, so here’s what you must do; and recent ASX biotech winners
News
Closing Bell: Webjet to split, BHP’s deadline dilemma, and Charger Metals up 70pc on lithium find
Health & Biotech
ASX Quarterly Health Wrap: LTR Pharma firms up trial recruitment as Dimerix achieves key milestone
Health & Biotech
Which ASX companies are resurrecting abandoned drugs? Part 2
News
Closing Bell: ASX gains as lithium, iron ore miners dazzle; copper and gold stocks extend rally
News
ASX Small Caps Lunch Wrap: Anyone else feeling a little forgetful this morning?
Health & Biotech
ASX Health Stocks: Argenica flies over 15pc after FDA grants Rare Pediatric Disease Designation
Health & Biotech
LTR Pharma commences dosing for pivotal erectile dysfunction study of SPONTAN
Health & Biotech
ASX stocks striving to inject youthfulness into an aging world population
News
Closing Bell: Local markets ride commodities higher after a blow to US confidence on Friday
Health & Biotech
ASX Health Stocks: Starpharma suffers setback as FDA rejects appeal, shares down 10pc
Health & Biotech
LTR Pharma firms up study for erectile dysfunction with patient recruitment
News
ASX Small Caps Lunch Wrap: Is this the weaponised AI we’re supposed to be scared of?
Health & Biotech
ASX Health Stocks: LTP is recruiting for patients to try its erection spray
News
